Annual Net Income
$845.04 M
+$165.95 M+24.44%
31 December 2023
Summary:
IDEXX Laboratories annual net profit is currently $845.04 million, with the most recent change of +$165.95 million (+24.44%) on 31 December 2023. During the last 3 years, it has risen by +$100.20 million (+13.45%). IDXX annual net income is now at all-time high.IDXX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$232.84 M
+$29.54 M+14.53%
30 September 2024
Summary:
IDEXX Laboratories quarterly net profit is currently $232.84 million, with the most recent change of +$29.54 million (+14.53%) on 30 September 2024. Over the past year, it has increased by +$38.32 million (+19.70%). IDXX quarterly net income is now -1.16% below its all-time high of $235.58 million, reached on 31 March 2024.IDXX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$866.24 M
+$20.61 M+2.44%
30 September 2024
Summary:
IDEXX Laboratories TTM net profit is currently $866.24 million, with the most recent change of +$20.61 million (+2.44%) on 30 September 2024. Over the past year, it has increased by +$21.20 million (+2.51%). IDXX TTM net income is now -0.04% below its all-time high of $866.57 million, reached on 31 March 2024.IDXX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +19.7% | +2.5% |
| 3 y3 years | +13.4% | +43.0% | +16.3% |
| 5 y5 years | +97.6% | +157.3% | +102.5% |
IDXX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.4% | -1.2% | +76.4% | -0.0% | +30.5% |
| 5 y | 5 years | at high | +97.6% | -1.2% | +157.3% | -0.0% | +102.5% |
| alltime | all time | at high | +4104.9% | -1.2% | +873.6% | -0.0% | +4186.0% |
IDEXX Laboratories Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $232.84 M(+14.5%) | $866.24 M(+2.4%) |
| June 2024 | - | $203.30 M(-13.7%) | $845.63 M(-2.4%) |
| Mar 2024 | - | $235.58 M(+21.1%) | $866.57 M(+2.5%) |
| Dec 2023 | $845.04 M(+24.4%) | $194.52 M(-8.3%) | $845.04 M(+2.7%) |
| Sept 2023 | - | $212.23 M(-5.4%) | $822.73 M(+4.0%) |
| June 2023 | - | $224.24 M(+4.8%) | $791.43 M(+13.2%) |
| Mar 2023 | - | $214.05 M(+24.3%) | $699.18 M(+3.0%) |
| Dec 2022 | $679.09 M(-8.8%) | $172.21 M(-4.8%) | $679.09 M(+1.4%) |
| Sept 2022 | - | $180.94 M(+37.1%) | $669.65 M(+0.9%) |
| June 2022 | - | $131.98 M(-32.0%) | $663.95 M(-9.6%) |
| Mar 2022 | - | $193.97 M(+19.2%) | $734.55 M(-1.4%) |
| Dec 2021 | $744.85 M(+28.0%) | $162.77 M(-7.1%) | $744.85 M(-1.6%) |
| Sept 2021 | - | $175.24 M(-13.5%) | $756.86 M(+4.0%) |
| June 2021 | - | $202.58 M(-0.8%) | $727.85 M(+8.0%) |
| Mar 2021 | - | $204.26 M(+16.9%) | $674.21 M(+15.9%) |
| Dec 2020 | $581.78 M(+36.0%) | $174.79 M(+19.5%) | $581.78 M(+16.9%) |
| Sept 2020 | - | $146.22 M(-1.8%) | $497.48 M(+8.1%) |
| June 2020 | - | $148.94 M(+33.2%) | $460.10 M(+5.3%) |
| Mar 2020 | - | $111.83 M(+23.6%) | $436.87 M(+2.1%) |
| Dec 2019 | $427.72 M(+13.4%) | $90.50 M(-16.9%) | $427.72 M(+1.1%) |
| Sept 2019 | - | $108.84 M(-13.4%) | $422.86 M(+3.8%) |
| June 2019 | - | $125.71 M(+22.4%) | $407.28 M(+4.4%) |
| Mar 2019 | - | $102.68 M(+19.9%) | $390.26 M(+3.5%) |
| Dec 2018 | $377.03 M(+43.3%) | $85.64 M(-8.2%) | $377.03 M(+14.4%) |
| Sept 2018 | - | $93.25 M(-14.2%) | $329.65 M(+7.4%) |
| June 2018 | - | $108.69 M(+21.5%) | $306.91 M(+8.2%) |
| Mar 2018 | - | $89.45 M(+133.8%) | $283.58 M(+7.8%) |
| Dec 2017 | $263.14 M(+18.5%) | $38.26 M(-45.7%) | $263.14 M(-5.1%) |
| Sept 2017 | - | $70.51 M(-17.4%) | $277.26 M(+5.3%) |
| June 2017 | - | $85.36 M(+23.7%) | $263.20 M(+7.4%) |
| Mar 2017 | - | $69.02 M(+31.8%) | $245.04 M(+10.4%) |
| Dec 2016 | $222.04 M(+15.6%) | $52.37 M(-7.2%) | $222.04 M(+3.7%) |
| Sept 2016 | - | $56.45 M(-16.0%) | $214.03 M(+6.1%) |
| June 2016 | - | $67.20 M(+46.0%) | $201.79 M(+5.4%) |
| Mar 2016 | - | $46.02 M(+3.8%) | $191.50 M(-0.3%) |
| Dec 2015 | $192.08 M(+5.6%) | $44.35 M(+0.3%) | $192.08 M(+10.6%) |
| Sept 2015 | - | $44.22 M(-22.3%) | $173.69 M(-4.4%) |
| June 2015 | - | $56.91 M(+22.1%) | $181.61 M(-0.2%) |
| Mar 2015 | - | $46.59 M(+79.5%) | $181.91 M(+0.0%) |
| Dec 2014 | $181.91 M(-3.1%) | $25.96 M(-50.2%) | $181.91 M(-8.7%) |
| Sept 2014 | - | $52.14 M(-8.9%) | $199.20 M(+3.3%) |
| June 2014 | - | $57.22 M(+22.8%) | $192.75 M(+1.7%) |
| Mar 2014 | - | $46.59 M(+7.7%) | $189.53 M(+0.9%) |
| Dec 2013 | $187.80 M(+5.3%) | $43.26 M(-5.3%) | $187.80 M(-0.1%) |
| Sept 2013 | - | $45.69 M(-15.4%) | $187.90 M(+1.5%) |
| June 2013 | - | $53.99 M(+20.4%) | $185.06 M(+1.5%) |
| Mar 2013 | - | $44.86 M(+3.5%) | $182.38 M(+2.3%) |
| Dec 2012 | $178.27 M(+10.2%) | $43.35 M(+1.2%) | $178.27 M(+3.1%) |
| Sept 2012 | - | $42.85 M(-16.5%) | $172.92 M(+2.6%) |
| June 2012 | - | $51.32 M(+26.0%) | $168.58 M(+1.6%) |
| Mar 2012 | - | $40.74 M(+7.2%) | $165.92 M(+2.6%) |
| Dec 2011 | $161.79 M(+14.5%) | $38.01 M(-1.3%) | $161.79 M(+1.0%) |
| Sept 2011 | - | $38.51 M(-20.9%) | $160.15 M(+2.4%) |
| June 2011 | - | $48.66 M(+32.9%) | $156.33 M(+7.9%) |
| Mar 2011 | - | $36.61 M(+0.7%) | $144.87 M(+2.5%) |
| Dec 2010 | $141.28 M(+15.6%) | $36.37 M(+4.8%) | $141.28 M(+4.0%) |
| Sept 2010 | - | $34.69 M(-6.7%) | $135.86 M(+2.4%) |
| June 2010 | - | $37.19 M(+12.6%) | $132.71 M(+2.7%) |
| Mar 2010 | - | $33.03 M(+6.7%) | $129.18 M(+5.7%) |
| Dec 2009 | $122.22 M(+5.2%) | $30.95 M(-1.9%) | $122.22 M(+6.4%) |
| Sept 2009 | - | $31.54 M(-6.3%) | $114.83 M(+5.4%) |
| June 2009 | - | $33.67 M(+29.1%) | $108.99 M(-5.0%) |
| Mar 2009 | - | $26.07 M(+10.7%) | $114.69 M(-1.3%) |
| Dec 2008 | $116.17 M(+23.6%) | $23.55 M(-8.3%) | $116.17 M(-1.7%) |
| Sept 2008 | - | $25.70 M(-34.7%) | $118.14 M(-0.1%) |
| June 2008 | - | $39.36 M(+42.9%) | $118.24 M(+17.6%) |
| Mar 2008 | - | $27.55 M(+7.9%) | $100.54 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $94.01 M(+0.4%) | $25.53 M(-1.0%) | $94.01 M(+0.9%) |
| Sept 2007 | - | $25.80 M(+19.1%) | $93.16 M(+0.9%) |
| June 2007 | - | $21.66 M(+3.0%) | $92.32 M(-4.3%) |
| Mar 2007 | - | $21.03 M(-14.8%) | $96.43 M(+2.9%) |
| Dec 2006 | $93.68 M(+19.7%) | $24.67 M(-1.1%) | $93.68 M(+5.2%) |
| Sept 2006 | - | $24.95 M(-3.2%) | $89.03 M(+5.1%) |
| June 2006 | - | $25.78 M(+41.1%) | $84.68 M(+7.4%) |
| Mar 2006 | - | $18.27 M(-8.8%) | $78.84 M(+0.7%) |
| Dec 2005 | $78.25 M(-0.1%) | $20.03 M(-2.8%) | $78.25 M(+4.1%) |
| Sept 2005 | - | $20.60 M(+3.4%) | $75.16 M(+1.2%) |
| June 2005 | - | $19.93 M(+12.7%) | $74.25 M(-5.1%) |
| Mar 2005 | - | $17.69 M(+4.5%) | $78.23 M(-0.1%) |
| Dec 2004 | $78.33 M(+37.2%) | $16.93 M(-14.0%) | $78.33 M(+6.2%) |
| Sept 2004 | - | $19.70 M(-17.6%) | $73.76 M(+5.3%) |
| June 2004 | - | $23.91 M(+34.4%) | $70.04 M(+11.5%) |
| Mar 2004 | - | $17.79 M(+43.9%) | $62.82 M(+10.0%) |
| Dec 2003 | $57.09 M(+25.8%) | $12.37 M(-22.6%) | $57.09 M(-0.7%) |
| Sept 2003 | - | $15.97 M(-4.3%) | $57.48 M(+6.5%) |
| June 2003 | - | $16.69 M(+38.4%) | $53.99 M(+7.4%) |
| Mar 2003 | - | $12.06 M(-5.4%) | $50.27 M(+10.7%) |
| Dec 2002 | $45.39 M(+20.7%) | $12.76 M(+2.2%) | $45.39 M(+6.9%) |
| Sept 2002 | - | $12.48 M(-3.7%) | $42.46 M(+5.6%) |
| June 2002 | - | $12.96 M(+80.4%) | $40.19 M(+8.1%) |
| Mar 2002 | - | $7.18 M(-26.9%) | $37.20 M(-1.1%) |
| Dec 2001 | $37.62 M(+2.7%) | $9.83 M(-3.8%) | $37.62 M(+0.1%) |
| Sept 2001 | - | $10.22 M(+2.5%) | $37.59 M(+2.6%) |
| June 2001 | - | $9.97 M(+31.0%) | $36.65 M(+1.2%) |
| Mar 2001 | - | $7.61 M(-22.4%) | $36.21 M(-1.2%) |
| Dec 2000 | $36.63 M(+12.4%) | $9.80 M(+5.7%) | $36.63 M(+2.5%) |
| Sept 2000 | - | $9.27 M(-2.7%) | $35.73 M(+2.5%) |
| June 2000 | - | $9.53 M(+18.6%) | $34.86 M(+4.6%) |
| Mar 2000 | - | $8.03 M(-9.7%) | $33.33 M(+2.3%) |
| Dec 1999 | $32.60 M(-314.5%) | $8.90 M(+6.0%) | $32.60 M(-609.4%) |
| Sept 1999 | - | $8.40 M(+5.0%) | -$6.40 M(-27.3%) |
| June 1999 | - | $8.00 M(+9.6%) | -$8.80 M(-24.8%) |
| Mar 1999 | - | $7.30 M(-124.3%) | -$11.70 M(-23.0%) |
| Dec 1998 | -$15.20 M(-28.0%) | -$30.10 M(-601.7%) | -$15.20 M(-228.8%) |
| Sept 1998 | - | $6.00 M(+17.6%) | $11.80 M(-206.3%) |
| June 1998 | - | $5.10 M(+34.2%) | -$11.10 M(-39.3%) |
| Mar 1998 | - | $3.80 M(-222.6%) | -$18.30 M(-13.7%) |
| Dec 1997 | -$21.10 M(-164.7%) | -$3.10 M(-81.7%) | -$21.20 M(+138.2%) |
| Sept 1997 | - | -$16.90 M(+704.8%) | -$8.90 M(-153.6%) |
| June 1997 | - | -$2.10 M(-333.3%) | $16.60 M(-37.6%) |
| Mar 1997 | - | $900.00 K(-90.2%) | $26.60 M(-18.7%) |
| Dec 1996 | $32.60 M(+51.6%) | $9.20 M(+7.0%) | $32.70 M(+6.9%) |
| Sept 1996 | - | $8.60 M(+8.9%) | $30.60 M(+11.7%) |
| June 1996 | - | $7.90 M(+12.9%) | $27.40 M(+12.3%) |
| Mar 1996 | - | $7.00 M(-1.4%) | $24.40 M(+14.0%) |
| Dec 1995 | $21.50 M(+61.7%) | $7.10 M(+31.5%) | $21.40 M(+15.1%) |
| Sept 1995 | - | $5.40 M(+10.2%) | $18.60 M(+10.7%) |
| June 1995 | - | $4.90 M(+22.5%) | $16.80 M(+15.9%) |
| Mar 1995 | - | $4.00 M(-7.0%) | $14.50 M(+9.0%) |
| Dec 1994 | $13.30 M(+37.1%) | $4.30 M(+19.4%) | $13.30 M(+4.7%) |
| Sept 1994 | - | $3.60 M(+38.5%) | $12.70 M(+8.5%) |
| June 1994 | - | $2.60 M(-7.1%) | $11.70 M(+4.5%) |
| Mar 1994 | - | $2.80 M(-24.3%) | $11.20 M(+14.3%) |
| Dec 1993 | $9.70 M(+98.0%) | $3.70 M(+42.3%) | $9.80 M(+25.6%) |
| Sept 1993 | - | $2.60 M(+23.8%) | $7.80 M(+16.4%) |
| June 1993 | - | $2.10 M(+50.0%) | $6.70 M(+15.5%) |
| Mar 1993 | - | $1.40 M(-17.6%) | $5.80 M(+18.4%) |
| Dec 1992 | $4.90 M(+53.1%) | $1.70 M(+13.3%) | $4.90 M(+8.9%) |
| Sept 1992 | - | $1.50 M(+25.0%) | $4.50 M(+12.5%) |
| June 1992 | - | $1.20 M(+140.0%) | $4.00 M(+17.6%) |
| Mar 1992 | - | $500.00 K(-61.5%) | $3.40 M(+6.3%) |
| Dec 1991 | $3.20 M | $1.30 M(+30.0%) | $3.20 M(+68.4%) |
| Sept 1991 | - | $1.00 M(+66.7%) | $1.90 M(+111.1%) |
| June 1991 | - | $600.00 K(+100.0%) | $900.00 K(+200.0%) |
| Mar 1991 | - | $300.00 K | $300.00 K |
FAQ
- What is IDEXX Laboratories annual net profit?
- What is the all time high annual net income for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly net profit?
- What is the all time high quarterly net income for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly net income year-on-year change?
- What is IDEXX Laboratories TTM net profit?
- What is the all time high TTM net income for IDEXX Laboratories?
- What is IDEXX Laboratories TTM net income year-on-year change?
What is IDEXX Laboratories annual net profit?
The current annual net income of IDXX is $845.04 M
What is the all time high annual net income for IDEXX Laboratories?
IDEXX Laboratories all-time high annual net profit is $845.04 M
What is IDEXX Laboratories quarterly net profit?
The current quarterly net income of IDXX is $232.84 M
What is the all time high quarterly net income for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly net profit is $235.58 M
What is IDEXX Laboratories quarterly net income year-on-year change?
Over the past year, IDXX quarterly net profit has changed by +$38.32 M (+19.70%)
What is IDEXX Laboratories TTM net profit?
The current TTM net income of IDXX is $866.24 M
What is the all time high TTM net income for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM net profit is $866.57 M
What is IDEXX Laboratories TTM net income year-on-year change?
Over the past year, IDXX TTM net profit has changed by +$21.20 M (+2.51%)